SEC Form 4 · accession 0001140361-16-077464
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary W Pace
Director
Period of report
Aug 19, 2016
Accepted (ET)
Aug 22, 2016 · 6:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Aug 19, 2016 | M | 36,000 | $25.54 | A | 129,158 | D | |
| ResMed Common Stock | Aug 19, 2016 | S | 36,000 | $69.926 | D | 93,158 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $25.54 | Aug 19, 2016 | M | 36,000 | D | Dec 17, 2012 | Dec 17, 2016 | ResMed Commmon Stock | 36,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $69.74 to $70.06. The price reported above reflects the weighted average sale price.
- F2Represents date options first became exercisable. Options vest one full year following the grant date.